A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.

Conditions: Relapsed/Refractory Multiple Myeloma Interventions: Drug: Equecabtagene Autoleucel Sponsors: Peking University People ' s Hospital Not yet recruiting

Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials